Anatara Lifesciences Ltd (AU:ANR) has released an update.
Anatara Lifesciences Ltd has announced the issue of 4.5 million director options as unquoted equity securities, set to be issued on July 9, 2024. These options are part of an employee incentive scheme and are not intended to be quoted on the ASX. This move could signal confidence in the company’s leadership and potential growth, possibly impacting investor interest.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.
